Gurugram: Covid-19 vaccines administered at 89 hospitals
"The 24 hour corona vaccine dose has already been started seven days a week in five hospitals which includes Civil hospital Sector 10, Medanta The Medicity, Artemis, Fortis and Max Hospital," Yadav said.
Gurugram: In Gurugram a rapid phase of the Covid-19 vaccination drive is being conducted in 89 hospitals. These include 37 government health centres and 52 private hospitals.
So far, 1,13,683 doses of the vaccine have been given in the district, the health officials said on Tuesday.
Also Read: China nod to new protein subunit COVID-19 vaccine for emergency use
Sharing more information, Virender Yadav, Chief Medical Officer (CMO), Gurugram, said that according to the instruction of the government, the vaccination drive is being conducted in the district.
According to the health officials, the vaccine doses are being given four days a week on Monday, Tuesday, Thursday and Friday in 37 government health centres and hospitals in the district. Similarly, in 52 private hospitals, doses of vaccine are being given daily from Monday to Saturday.
"The 24-hour corona vaccine dose has already been started seven days a week in five hospitals which includes Civil hospital Sector 10, Medanta The Medicity, Artemis, Fortis and Max Hospital," Yadav said.
Giving detailed information about the doses of Corona vaccine given in Gurugram district till now, District Immunisation Officer M.P. Singh said that as per the instruction of the government, till Monday evening, 26,278 persons in health care workers got the first dose and around 16,338 persons have been administered with the second dose of vaccine.
Similarly, in the case of front-line workers 18,759 persons have been given the first dose and 4508 persons have been given the second dose.
"During third phase of the vaccination drive 5,587 persons with severe diseases ranging from 45 years to 59 years have been given the first dose and 42,213 senior citizens above the age of 60 years have been given the first dose of vaccine," Singh informed.
Also Read: Serum Institute secures CDSCO panel nod for bridge trial of Novavax Covid-19 vaccine
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.